New registry to reveal how well anemia drug works in real kidney patients
NCT ID NCT07346547
First seen Jan 25, 2026 · Last updated May 25, 2026 · Updated 18 times
Summary
This study will follow 384 adults with chronic kidney disease (CKD) and anemia who are taking or starting the drug daprodustat. Researchers will track hemoglobin levels, heart problems, hospital stays, and patient well-being to understand how the drug works in everyday practice. The goal is to improve treatment guidelines and care for CKD anemia.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.